Publication: Prevalence and associated factors of non-uptake of human immunodeficiency virus testing of tuberculosis patients in Thailand
Issued Date
2015
Resource Type
Language
eng
ISSN
1905-1387
Rights
Mahidol University
Rights Holder(s)
ASEAN Institute for Health Development. Mahidol University
Bibliographic Citation
Journal of Public Health and Development. Vol.13, No.1 (2015), 29-36
Suggested Citation
Supa Pengpid, Karl Peltzer Prevalence and associated factors of non-uptake of human immunodeficiency virus testing of tuberculosis patients in Thailand. Journal of Public Health and Development. Vol.13, No.1 (2015), 29-36. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/1571
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Prevalence and associated factors of non-uptake of human immunodeficiency virus testing of tuberculosis patients in Thailand
Author(s)
Other Contributor(s)
Abstract
The aim of this study is to assess the prevalence and associated factors of non-uptake of human
immunodeficiency virus (HIV) testing by tuberculosis hospital patients in Thailand. In 2014, a cross-sectional
survey was conducted among 425 tuberculosis (TB) patients from 42 public hospitals (21 provincial and
21 district hospitals), in 21 provinces, from all four regions in Thailand. All new TB and new retreatment
patients were interviewed within one month of anti-tuberculosis treatment. The outcome was self-reported
HIV testing after TB diagnosis.
Results indicated that 38.4% of the 425 participants had not undergone HIV testing. Multiple logistic
regression found that 61 years and older and being a Thai national were significantly associated with “Not
tested for HIV”, while other socio-demographic factors, residential status, TB diagnosis characteristics, TB
treatment status, TB knowledge, substance use and TB-AIDS stigma were not significantly associated with
“Not tested for HIV”. In conclusion, the level of HIV testing among TB hospital patients was suboptimal,
and the Ministry of Public Health should continue to scale-up HIV testing and other collaborative TB-HIV
services at health facilities.